Publications Database

Bersani F. et al. (2013)

Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: A comprehensive review.

European Psychiatry

January, 28(1), pp. 30-39.

Read Abstract (New Window)

Caccia S. (2013)

Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.

Pediatric Drugs

15(3), pp. 217-233.

Read Abstract (New Window)

Campbell M. et al. (1972)

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children.

Journal of Autism and Developmental Disorders

2(4),

Read Abstract (New Window)

Cochran D. M. , Dvir Y. , Frazier J. (2013)

'Autism-plus' spectrum disorders: Intersection with psychosis and the schizophrenia spectrum.

Child and Adolescent Psychiatric Clinics of North America

22(4), pp. 609-627.

Read Abstract (New Window)

Croen L. A. et al. (2015)

The health status of adults on the autism spectrum.

Autism

October, 19(7), pp. 814-823.

Read Abstract (New Window)

DeMyer M. K. , Hingtgen J. N. , Jackson R. K. (1981)

Infantile autism reviewed: A decade of research.

Schizophrenia Bulletin

7(3), pp. 388-451.

Read Abstract (New Window) Read Full (New Window)

Esterberg M. L. et al. (2008)

Childhood and current autistic features in adolescents with schizotypal personality disorder.

Schizophrenia Research

104(1), pp. 265-273.

Read Abstract (New Window)

Faretra G. , Dooher L. , Dowling J. (1970)

Comparison of haloperidol and fluphenazine in disturbed children.

American Journal of Psychiatry

126(11), pp. 1670-1673.

Read Abstract (New Window)

Hingtgen J. N. (1972)

Recent developments in the study of early childhood psychoses: Infantile autism, childhood schizophrenia, and related disorders.

Schizophrenia Bulletin

5 pp. 8-54

Johnson M. (2012)

Executive function and developmental disorders: the flip side of the coin.

Trends in Cognitive Sciences

16(9), pp. 454-457.

Read Abstract (New Window)

Kanner L. (1943)

Autistic disturbances of affective contact.

Nervous Child

2 pp. 217-250.

Read Full (New Window)

Keech B. , Crowe S. , Hocking D. R. (2018)

Intranasal oxytocin, social cognition and neurodevelopmental disorders: A meta-analysis

Psychoneuroendocrinology

87 pp. 9-19.

Read Abstract (New Window)

Kincaid D. L. et al. (2017)

What is the prevalence of autism spectrum disorder and ASD traits in psychosis? A systematic review.

Psychiatry Research

250 pp. 99–105.

Read Abstract (New Window)

Kohane I. S. et al. (2012)

The co-morbidity burden of children and young adults with autism spectrum disorders.

PLoS ONE

7(4), e33224

Read Abstract (New Window) Read Full (New Window)

LaPerchia P. (1987)

Behavioral disorders, learning disabilities and megavitamin therapy.

Adolescence

22(87), pp. 729-738

Read Abstract (New Window)

Marazziti D. , Dell'osso M. (2008)

The role of oxytocin in neuropsychiatric disorders.

Current Medicinal Chemistry

15(7), pp. 698-704

Read Abstract (New Window)

McKinney C. , Renk K. (2011)

Atypical antipsychotic medications in the management of disruptive behaviors in children: Safety guidelines and recommendations.

Clinical Psychology Review

31(3), pp. .465-471.

Read Abstract (New Window)

Politi P. et al. (2013)

Randomized placebo-controlled trials of omega-3 polyunsaturated fatty acids in psychiatric disorders: a review of current literature.

Current Drug Discovery Techniques

10(3), pp. 245-253.

Read Abstract (New Window)

Rapoport J. L. et al. (2009)

Autism spectrum disorders and childhood-onset schizophrenia: clinical and biological contributions to a relation revisited.

Journal of the American Academy of Child and Adolescent Psychiatry

48(1), pp. 10-18

Read Abstract (New Window) Read Full (New Window)

Richardson A. J. (2003)

The role of omega 3 fatty acids in behaviour, cognition and mood.

Scandinavian Journal of Nutrition

47(2), pp. 92-98

Read Abstract (New Window)